LIMN · Liminatus Pharma, Inc. · Analyst Estimates
$2.82
-0.08 (-2.59%)
At close · Oct 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with the Company's assessment of going concern considerations in accordance with Financial Accounting Standards Board ("FASB") ASC 205-40, Presentation of Financial Statements—Going Concern, management has concluded that there is substantial doubt about its ability to continue as a going concern for one year after the date that the accompanying unaudited condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$3.79M
Shares
1.34M
Volume · Oct 30
12.98K
Avg daily vol (50 sessions)
31.68K
Analyst Estimates
Compare analyst forecasts for Liminatus Pharma, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
This verified capture contains no analyst forecast observations. Older snapshots remain in the history.
Captured 2026-09-18 20:32 UTC · Publication dates shown per estimate · 0 metric / period groups